Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan C Fox

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Journal of Clinical Hypertension (Greenwich, Conn.)|August 17, 2004
The JNC 7 approach compared to conventional treatment in diabetic patients with hypertension: a double-blind trial of initial monotherapy vs. combination therapyJonathan C Fox, Kellie Leight, Santosh C Sutradhar, et al.
Human Gene Therapy|January 16, 2013
Restoration of cytoskeleton homeostasis after gigaxonin gene transfer for giant axonal neuropathySilke Mussche, Bart Devreese, Sahana Nagabhushan Kalburgi, et al.
Future Cardiology|January 29, 2025
Comparison of in-clinic assessment of 6MWT by conventional method and using wearable sensors for patients with ATTR-CMPrem Soman, Michel G Khouri, Daniel Lenihan, et al.
Pharmacoepidemiology and Drug Safety|June 9, 2006
The comparative safety of rosuvastatin: a retrospective matched cohort study in over 48,000 initiators of statin therapyAndrew T McAfee, Eileen E Ming, John D Seeger, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 26, 2022
Autosomal Dominant Hypocalcemia Type 1: A Systematic ReviewKelly L Roszko, Lyndsay M Stapleton Smith, Ananth V Sridhar, et al.
The New England Journal of Medicine|September 27, 2023
Efficacy and Safety of Encaleret in Autosomal Dominant Hypocalcemia Type 1Rachel I Gafni, Iris R Hartley, Kelly L Roszko, et al.
JACC. Cardiooncology|June 17, 2026
Differential Transthyretin Stabilization in Patients With Wild Type and Variant Transthyretin AmyloidosisDaniel P Judge, Alan X Ji, Isabella A Graef, et al.
Journal of Cardiac Failure|April 11, 2025
Acoramidis for Transthyretin Amyloid Cardiomyopathy: Open-Label Extension Study Long-Term Follow-UpAhmad Masri, Mandar Aras, Martha Grogan, et al.
European Journal of Heart Failure|May 30, 2026
Outpatient worsening heart failure in transthyretin amyloid cardiomyopathy: Findings from ATTRibute-CMMarianna Fontana, Francesco Cappelli, Pablo Garcia-Pavia, et al.
European Journal of Heart Failure|March 2, 2026
Impact of acoramidis on clinical stability in transthyretin amyloid cardiomyopathy: Observations from ATTRibute-CMFrancesco Cappelli, Marianna Fontana, Pablo Garcia-Pavia, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Journal of Clinical Hypertension (Greenwich, Conn.)|August 17, 2004
The JNC 7 approach compared to conventional treatment in diabetic patients with hypertension: a double-blind trial of initial monotherapy vs. combination therapyJonathan C Fox, Kellie Leight, Santosh C Sutradhar, et al.
Human Gene Therapy|January 16, 2013
Restoration of cytoskeleton homeostasis after gigaxonin gene transfer for giant axonal neuropathySilke Mussche, Bart Devreese, Sahana Nagabhushan Kalburgi, et al.
Future Cardiology|January 29, 2025
Comparison of in-clinic assessment of 6MWT by conventional method and using wearable sensors for patients with ATTR-CMPrem Soman, Michel G Khouri, Daniel Lenihan, et al.
Pharmacoepidemiology and Drug Safety|June 9, 2006
The comparative safety of rosuvastatin: a retrospective matched cohort study in over 48,000 initiators of statin therapyAndrew T McAfee, Eileen E Ming, John D Seeger, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 26, 2022
Autosomal Dominant Hypocalcemia Type 1: A Systematic ReviewKelly L Roszko, Lyndsay M Stapleton Smith, Ananth V Sridhar, et al.
The New England Journal of Medicine|September 27, 2023
Efficacy and Safety of Encaleret in Autosomal Dominant Hypocalcemia Type 1Rachel I Gafni, Iris R Hartley, Kelly L Roszko, et al.
JACC. Cardiooncology|June 17, 2026
Differential Transthyretin Stabilization in Patients With Wild Type and Variant Transthyretin AmyloidosisDaniel P Judge, Alan X Ji, Isabella A Graef, et al.
Journal of Cardiac Failure|April 11, 2025
Acoramidis for Transthyretin Amyloid Cardiomyopathy: Open-Label Extension Study Long-Term Follow-UpAhmad Masri, Mandar Aras, Martha Grogan, et al.
European Journal of Heart Failure|May 30, 2026
Outpatient worsening heart failure in transthyretin amyloid cardiomyopathy: Findings from ATTRibute-CMMarianna Fontana, Francesco Cappelli, Pablo Garcia-Pavia, et al.
European Journal of Heart Failure|March 2, 2026
Impact of acoramidis on clinical stability in transthyretin amyloid cardiomyopathy: Observations from ATTRibute-CMFrancesco Cappelli, Marianna Fontana, Pablo Garcia-Pavia, et al.
Pageof 4